| Pulmonary hypertension in chronic liver disease. | |
| | |
MedLine Citation:
|
PMID: 8665788 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pulmonary hypertension develops in approximately 2% of patients with portal hypertension. Diagnosis is often difficult and requires a high degree of clinical suspicion. Treatment of patients with portal and pulmonary hypertension is limited, and mean survival following diagnosis is approximately 15 months. The effect of liver transplantation on the natural history of disease is discussed. |
| | |
Authors:
|
M S Mandell; B M Groves |
Related Documents
:
|
20216168 - Nursing considerations in the care of patients with pulmonary hypertension. 2252188 - Life-threatening complications during anaesthesia in a patient with a ventriculo-atrial... 18200808 - Review of bosentan in the management of pulmonary arterial hypertension. 12391278 - Cyclooxygenase-2 acts as an endogenous brake on endothelin-1 release by human pulmonary... 19692438 - Aortic posterior wall perforation with automatic aortic cutter during routine off-pump ... 23124408 - Aortic valve insufficiency in antinuclear antibody positive large vessel vasculitis. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinics in chest medicine Volume: 17 ISSN: 0272-5231 ISO Abbreviation: Clin. Chest Med. Publication Date: 1996 Mar |
Date Detail:
|
Created Date: 1996-08-08 Completed Date: 1996-08-08 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7907612 Medline TA: Clin Chest Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 17-33 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chronic Disease Endothelium, Vascular Humans Hypertension, Portal / complications*, diagnosis, surgery Hypertension, Pulmonary / diagnosis, drug therapy, etiology*, mortality, physiopathology Liver Diseases / complications, physiopathology, surgery Liver Transplantation Lung / blood supply Prognosis Survival Rate Vasodilator Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Vasodilator Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mediators, cytokines, and growth factors in liver-lung interactions.
Next Document: Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease.